Elevated serum tetrac in graves disease

Potential pathogenic role in thyroid-associated ophthalmopathy

Roshini Fernando, Ekaterina Placzek, Edmund A. Reese, Andrew T. Placzek, Samantha Schwartz, Aaron Trierweiler, Leslie M. Niziol, Nupur Raychaudhuri, Stephen Atkins, Thomas (Tom) Scanlan, Terry J. Smith

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Context: The sources and biological impact of 3,30,5,50 tetraiodothyroacetic acid (TA4) are uncertain. CD34+ fibrocytes express several proteins involved in the production of thyroid hormones. They infiltrate the orbit in Graves disease (GD), an autoimmune process known as thyroid-associated ophthalmopathy. It appears that the thyrotropin receptor plays an important role in the pathogenesis of thyroid-associated ophthalmopathy. Objective: To quantify levels of TA4 in healthy participants and those with GD, determine whether fibrocytes generate this thyroid hormone analogue, and determine whether TA4 influences the actions of thyroid-stimulating hormone and thyroid-stimulating immunoglobulins in orbital fibroblasts. Design/Setting/Participants: Patients with GD and healthy donors in an academic medical center clinical practice were recruited. Main Outcome Measures: Liquid chromatography-tandem mass spectrometry, autoradiography, real-time polymerase chain reaction, hyaluronan immunoassay. Results: Serum levels of TA4 are elevated in GD. TA4 levels are positively correlated with those of thyroxine and negatively correlated with serum levels of triiodothyronine. Several cell types in culture generate TA4 from ambient thyroxine, including fibrocytes, HELA cells, human Müller stem cells, and retinal pigmented epithelial cells. Propylthiouracil inhibits TA4 generation. TA4 enhances the induction by thyrotropin and thyroid-stimulating immunoglobulins of several participants in the pathogenesis of thyroid-associated ophthalmopathy, including interleukin 6, hyaluronan synthase 1, prostaglandin endoperoxide H synthase 2, and haluronan production. Conclusion: TA4 may be ubiquitously generated in many tissues and enhances the biological impact of thyrotropin and thyroid-stimulating immunoglobulins in orbital connective tissue. These findings may identify a physiologically important determinant of extrathyroidal thyroid-stimulating hormone action.

Original languageEnglish (US)
Pages (from-to)776-785
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume102
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Graves Ophthalmopathy
Graves Disease
Thyroid-Stimulating Immunoglobulins
Thyrotropin
Serum
Thyroxine
Thyroid Hormones
Prostaglandin Endoperoxides
Tissue
Propylthiouracil
Thyrotropin Receptors
Polymerase chain reaction
Liquid chromatography
Triiodothyronine
Orbit
Hyaluronic Acid
Cyclooxygenase 2
Fibroblasts
Prostaglandin-Endoperoxide Synthases
Tandem Mass Spectrometry

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Fernando, R., Placzek, E., Reese, E. A., Placzek, A. T., Schwartz, S., Trierweiler, A., ... Smith, T. J. (2017). Elevated serum tetrac in graves disease: Potential pathogenic role in thyroid-associated ophthalmopathy. Journal of Clinical Endocrinology and Metabolism, 102(3), 776-785. https://doi.org/10.1210/jc.2016-2762

Elevated serum tetrac in graves disease : Potential pathogenic role in thyroid-associated ophthalmopathy. / Fernando, Roshini; Placzek, Ekaterina; Reese, Edmund A.; Placzek, Andrew T.; Schwartz, Samantha; Trierweiler, Aaron; Niziol, Leslie M.; Raychaudhuri, Nupur; Atkins, Stephen; Scanlan, Thomas (Tom); Smith, Terry J.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 102, No. 3, 01.03.2017, p. 776-785.

Research output: Contribution to journalArticle

Fernando, R, Placzek, E, Reese, EA, Placzek, AT, Schwartz, S, Trierweiler, A, Niziol, LM, Raychaudhuri, N, Atkins, S, Scanlan, TT & Smith, TJ 2017, 'Elevated serum tetrac in graves disease: Potential pathogenic role in thyroid-associated ophthalmopathy', Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 3, pp. 776-785. https://doi.org/10.1210/jc.2016-2762
Fernando, Roshini ; Placzek, Ekaterina ; Reese, Edmund A. ; Placzek, Andrew T. ; Schwartz, Samantha ; Trierweiler, Aaron ; Niziol, Leslie M. ; Raychaudhuri, Nupur ; Atkins, Stephen ; Scanlan, Thomas (Tom) ; Smith, Terry J. / Elevated serum tetrac in graves disease : Potential pathogenic role in thyroid-associated ophthalmopathy. In: Journal of Clinical Endocrinology and Metabolism. 2017 ; Vol. 102, No. 3. pp. 776-785.
@article{a91ea3aeb3f242a982ff07e3b0f833d3,
title = "Elevated serum tetrac in graves disease: Potential pathogenic role in thyroid-associated ophthalmopathy",
abstract = "Context: The sources and biological impact of 3,30,5,50 tetraiodothyroacetic acid (TA4) are uncertain. CD34+ fibrocytes express several proteins involved in the production of thyroid hormones. They infiltrate the orbit in Graves disease (GD), an autoimmune process known as thyroid-associated ophthalmopathy. It appears that the thyrotropin receptor plays an important role in the pathogenesis of thyroid-associated ophthalmopathy. Objective: To quantify levels of TA4 in healthy participants and those with GD, determine whether fibrocytes generate this thyroid hormone analogue, and determine whether TA4 influences the actions of thyroid-stimulating hormone and thyroid-stimulating immunoglobulins in orbital fibroblasts. Design/Setting/Participants: Patients with GD and healthy donors in an academic medical center clinical practice were recruited. Main Outcome Measures: Liquid chromatography-tandem mass spectrometry, autoradiography, real-time polymerase chain reaction, hyaluronan immunoassay. Results: Serum levels of TA4 are elevated in GD. TA4 levels are positively correlated with those of thyroxine and negatively correlated with serum levels of triiodothyronine. Several cell types in culture generate TA4 from ambient thyroxine, including fibrocytes, HELA cells, human M{\"u}ller stem cells, and retinal pigmented epithelial cells. Propylthiouracil inhibits TA4 generation. TA4 enhances the induction by thyrotropin and thyroid-stimulating immunoglobulins of several participants in the pathogenesis of thyroid-associated ophthalmopathy, including interleukin 6, hyaluronan synthase 1, prostaglandin endoperoxide H synthase 2, and haluronan production. Conclusion: TA4 may be ubiquitously generated in many tissues and enhances the biological impact of thyrotropin and thyroid-stimulating immunoglobulins in orbital connective tissue. These findings may identify a physiologically important determinant of extrathyroidal thyroid-stimulating hormone action.",
author = "Roshini Fernando and Ekaterina Placzek and Reese, {Edmund A.} and Placzek, {Andrew T.} and Samantha Schwartz and Aaron Trierweiler and Niziol, {Leslie M.} and Nupur Raychaudhuri and Stephen Atkins and Scanlan, {Thomas (Tom)} and Smith, {Terry J.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1210/jc.2016-2762",
language = "English (US)",
volume = "102",
pages = "776--785",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Elevated serum tetrac in graves disease

T2 - Potential pathogenic role in thyroid-associated ophthalmopathy

AU - Fernando, Roshini

AU - Placzek, Ekaterina

AU - Reese, Edmund A.

AU - Placzek, Andrew T.

AU - Schwartz, Samantha

AU - Trierweiler, Aaron

AU - Niziol, Leslie M.

AU - Raychaudhuri, Nupur

AU - Atkins, Stephen

AU - Scanlan, Thomas (Tom)

AU - Smith, Terry J.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Context: The sources and biological impact of 3,30,5,50 tetraiodothyroacetic acid (TA4) are uncertain. CD34+ fibrocytes express several proteins involved in the production of thyroid hormones. They infiltrate the orbit in Graves disease (GD), an autoimmune process known as thyroid-associated ophthalmopathy. It appears that the thyrotropin receptor plays an important role in the pathogenesis of thyroid-associated ophthalmopathy. Objective: To quantify levels of TA4 in healthy participants and those with GD, determine whether fibrocytes generate this thyroid hormone analogue, and determine whether TA4 influences the actions of thyroid-stimulating hormone and thyroid-stimulating immunoglobulins in orbital fibroblasts. Design/Setting/Participants: Patients with GD and healthy donors in an academic medical center clinical practice were recruited. Main Outcome Measures: Liquid chromatography-tandem mass spectrometry, autoradiography, real-time polymerase chain reaction, hyaluronan immunoassay. Results: Serum levels of TA4 are elevated in GD. TA4 levels are positively correlated with those of thyroxine and negatively correlated with serum levels of triiodothyronine. Several cell types in culture generate TA4 from ambient thyroxine, including fibrocytes, HELA cells, human Müller stem cells, and retinal pigmented epithelial cells. Propylthiouracil inhibits TA4 generation. TA4 enhances the induction by thyrotropin and thyroid-stimulating immunoglobulins of several participants in the pathogenesis of thyroid-associated ophthalmopathy, including interleukin 6, hyaluronan synthase 1, prostaglandin endoperoxide H synthase 2, and haluronan production. Conclusion: TA4 may be ubiquitously generated in many tissues and enhances the biological impact of thyrotropin and thyroid-stimulating immunoglobulins in orbital connective tissue. These findings may identify a physiologically important determinant of extrathyroidal thyroid-stimulating hormone action.

AB - Context: The sources and biological impact of 3,30,5,50 tetraiodothyroacetic acid (TA4) are uncertain. CD34+ fibrocytes express several proteins involved in the production of thyroid hormones. They infiltrate the orbit in Graves disease (GD), an autoimmune process known as thyroid-associated ophthalmopathy. It appears that the thyrotropin receptor plays an important role in the pathogenesis of thyroid-associated ophthalmopathy. Objective: To quantify levels of TA4 in healthy participants and those with GD, determine whether fibrocytes generate this thyroid hormone analogue, and determine whether TA4 influences the actions of thyroid-stimulating hormone and thyroid-stimulating immunoglobulins in orbital fibroblasts. Design/Setting/Participants: Patients with GD and healthy donors in an academic medical center clinical practice were recruited. Main Outcome Measures: Liquid chromatography-tandem mass spectrometry, autoradiography, real-time polymerase chain reaction, hyaluronan immunoassay. Results: Serum levels of TA4 are elevated in GD. TA4 levels are positively correlated with those of thyroxine and negatively correlated with serum levels of triiodothyronine. Several cell types in culture generate TA4 from ambient thyroxine, including fibrocytes, HELA cells, human Müller stem cells, and retinal pigmented epithelial cells. Propylthiouracil inhibits TA4 generation. TA4 enhances the induction by thyrotropin and thyroid-stimulating immunoglobulins of several participants in the pathogenesis of thyroid-associated ophthalmopathy, including interleukin 6, hyaluronan synthase 1, prostaglandin endoperoxide H synthase 2, and haluronan production. Conclusion: TA4 may be ubiquitously generated in many tissues and enhances the biological impact of thyrotropin and thyroid-stimulating immunoglobulins in orbital connective tissue. These findings may identify a physiologically important determinant of extrathyroidal thyroid-stimulating hormone action.

UR - http://www.scopus.com/inward/record.url?scp=85015237492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015237492&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-2762

DO - 10.1210/jc.2016-2762

M3 - Article

VL - 102

SP - 776

EP - 785

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -